Screener
Kiniksa Pharmaceuticals International, plc KNSA Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's free cash flow margin?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported free cash flow margin of 21.7% in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's free cash flow margin changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's free cash flow margin increased by 67.5% year-over-year, from 13% to 21.7%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's free cash flow margin?
- Over 3 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's free cash flow margin has grown at a -60.6% compound annual growth rate (CAGR), from -328.7% to 20.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Kiniksa Pharmaceuticals International, plc's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude